Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

When a lesion detected with one of these imaging techniques meets the criteria for hepatocellular carcinoma, confirmation of the diagnosis with biopsy is not needed. 6,8 Five months later and 6 ...

During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...

Mursla Bio, a Cambridge UK and Boston US leader in Extracellular Vesicle (EV) science, has received FDA approval for its lead ...

There are several different types of primary liver cancer. The most common type is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte). Other types of liver cancer, like ...

In this scenario, further imaging or biopsy is indicated ... considerable overlap in the appearance of metastases and hepatocellular carcinoma (HCC). [21] On a case-by-case basis, clinical ...

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.